Points to consider in the preclinical development of immunomodulatory drugs for the treatment of HIV infection and associated disorders

Category

Date Issued:

1992

DOI:

10.24355/dbbs.084-200812020100-9

URN:

urn:nbn:de:gbv:084-11032410419

Language:

English

Type of Resource:

Text

Extent:

13 S.

Place Term:

Rockville, MD

Publisher:

Center for Drug Evaluation and Research (CDER)

Keywords:

ViFaPharm

DDC:

615 Pharmazie, Pharmakologie, Therapie

URL:

http://www.digibib.tu-bs.de/?docid=00023955

Library shelfmark::

586164006